Explaining sex differences in risk of bloodstream infections using mediation analysis in the population-based HUNT study in Norway.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
19 05 2022
Historique:
received: 07 12 2021
accepted: 12 05 2022
entrez: 19 5 2022
pubmed: 20 5 2022
medline: 24 5 2022
Statut: epublish

Résumé

Previous studies indicate sex differences in incidence and severity of bloodstream infections (BSI). We examined the effect of sex on risk of BSI, BSI mortality, and BSI caused by the most common infecting bacteria. Using causal mediation analyses, we assessed if this effect is mediated by health behaviours (smoking, alcohol consumption), education, cardiovascular risk factors (systolic blood pressure, non-HDL cholesterol, body mass index) and selected comorbidities. This prospective study included 64,040 participants (46.8% men) in the population-based HUNT2 Survey (1995-1997) linked with hospital records in incident BSI. During median follow-up of 15.2 years, 1840 (2.9%) participants (51.3% men) experienced a BSI and 396 (0.6%) died (56.6% men). Men had 41% higher risk of first-time BSI (95% confidence interval (CI), 28-54%) than women. Together, health behaviours, education, cardiovascular risk factors and comorbidities mediated 34% of the excess risk of BSI observed in men. The HR of BSI mortality was 1.87 (95% CI 1.53-2.28), for BSI due to S. aureus 2.09 (1.28-2.54), S. pneumoniae 1.36 (1.05-1.76), E. coli 0.97 (0.84-1.13) in men vs women. This study shows that men have higher risk of BSI and BSI mortality than women. One-third of this effect was mediated by potential modifiable risk factors for incident BSI.

Identifiants

pubmed: 35589812
doi: 10.1038/s41598-022-12569-8
pii: 10.1038/s41598-022-12569-8
pmc: PMC9118181
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

8436

Informations de copyright

© 2022. The Author(s).

Références

Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990–2017: Analysis for the Global Burden of Disease Study. Lancet 395, 200–211 (2020).
Prescott, H. C., Osterholzer, J. J., Langa, K. M., Angus, D. C. & Iwashyna, T. J. Late mortality after sepsis: Propensity matched cohort study. BMJ 353, i2375 (2016).
Reddick, L. E. & Alto, N. M. Bacteria fighting back: How pathogens target and subvert the host innate immune system. Mol. Cell 54, 321–328 (2014).
Paulsen, J. et al. Associations of obesity and lifestyle with the risk and mortality of bloodstream infection in a general population: A 15-year follow-up of 64 027 individuals in the HUNT study. Int. J. Epidemiol. 46, 1573–1581 (2017).
Mohus, R. M. et al. Association of iron status with the risk of bloodstream infections: Results from the prospective population-based HUNT Study in Norway. Intens. Care Med. 44, 1276–1283 (2018).
Esper, A. M. et al. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit. Care Med. 34, 2576–2582 (2006).
Askim, A. et al. Anxiety and depression symptoms in a general population and future risk of bloodstream infection: The HUNT study. Psychosom. Med. 80, 673–679 (2018).
Moore, J. X. et al. Community characteristics and regional variations in sepsis. Int. J. Epidemiol. 46, 1607–1617 (2017).
Laupland, K. B. et al. Severe bloodstream infections: A population-based assessment. Crit. Care Med. 32, 992–997 (2004).
Pietropaoli, A. P., Glance, L. G., Oakes, D. & Fisher, S. G. Gender differences in mortality in patients with severe sepsis or septic shock. Gender Med. 7, 422–437 (2010).
Adrie, C. et al. Influence of gender on the outcome of severe sepsis: A reappraisal. Chest 132, 1786–1793 (2007).
Drozd, M. et al. Non-communicable disease, sociodemographic factors, and risk of death from infection: A UK Biobank observational cohort study. Lancet Infect. Dis. 21, 1184–1191 (2021).
Vázquez-Martínez, E. R., García-Gómez, E., Camacho-Arroyo, I. & González-Pedrajo, B. Sexual dimorphism in bacterial infections. Biol. Sex Differ. 9, 27 (2018).
Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626–638 (2016).
Uslan, D. Z. et al. Age- and sex-associated trends in bloodstream infection: A population-based study in Olmsted County, Minnesota. Arch. Intern. Med. 167, 834–839 (2007).
Laupland, K. B., Pasquill, K., Steele, L. & Parfitt, E. C. Burden of bloodstream infection in older persons: A population-based study. BMC Geriatr. 21, 31 (2021).
Laupland, K. B. Defining the epidemiology of bloodstream infections: The “gold standard” of population-based assessment. Epidemiol. Infect. 141, 2149–2157 (2013).
Mauvais-Jarvis, F. et al. Sex and gender: Modifiers of health, disease, and medicine. Lancet 396, 565–582 (2020).
World Health Organization. Addressing Sex and Gender in Epidemic-Prone Infectious Diseases (World Health Organization, 2007).
Laupland, K. B. et al. Population-based risk factors for community-onset bloodstream infections. Eur. J. Clin. Microbiol. Infect. Dis. 39, 753–758 (2020).
Lindström, A.-C., Eriksson, M., Mårtensson, J., Oldner, A. & Larsson, E. Nationwide case–control study of risk factors and outcomes for community-acquired sepsis. Sci. Rep. https://doi.org/10.1038/s41598-021-94558-x (2021).
doi: 10.1038/s41598-021-94558-x
VanderWeele, T. & Vansteelandt, S. Mediation analysis with multiple mediators. Epidemiol. Methods 2, 95–115 (2014).
Nguyen, Q. C., Osypuk, T. L., Schmidt, N. M., Glymour, M. M. & Tchetgen Tchetgen, E. J. Practical guidance for conducting mediation analysis with multiple mediators using inverse odds ratio weighting. Am. J. Epidemiol. 181, 349–356 (2015).
Krokstad, S. et al. Cohort profile: The HUNT study, Norway. Int. J. Epidemiol. 42, 968–977 (2012).
Mehl, A. et al. Burden of bloodstream infection in an area of Mid-Norway 2002–2013: A prospective population-based observational study. BMC Infect. Dis. 17, 205 (2017).
Lee, H. et al. A guideline for reporting mediation analyses of randomized trials and observational studies: The AGReMA statement. JAMA 326, 1045–1056 (2021).
Lee, H., Herbert, R. D. & McAuley, J. H. Mediation analysis. JAMA 321, 697–698 (2019).
Gerdts, E. & Regitz-Zagrosek, V. Sex differences in cardiometabolic disorders. Nat. Med. 25, 1657–1666 (2019).
Mauvais-Jarvis, F. Epidemiology of gender differences in diabetes and obesity. In Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity (ed. Mauvais-Jarvis, F.) 3–8 (Springer, 2017).
Antequera, A. et al. Sex as a prognostic factor for mortality in critically ill adults with sepsis: a systematic review and meta-analysis. BMJ Open. 11(9), e048982. https://doi.org/10.1136/bmjopen-2021-048982 (2021).
Preacher, K. J. & Hayes, A. F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav. Res. Methods 40, 879–891 (2008).
Libert, C., Dejager, L. & Pinheiro, I. The X chromosome in immune functions: When a chromosome makes the difference. Nat. Rev. Immunol. 10, 594–604 (2010).
Paulsen, J. et al. Epidemiology and outcome of Staphylococcus aureus bloodstream infection and sepsis in a Norwegian county 1996–2011: An observational study. BMC Infect. Dis. 15, 116 (2015).
Sakr, A., Brégeon, F., Mège, J. L., Rolain, J. M. & Blin, O. Staphylococcus aureus nasal colonization: An update on mechanisms, epidemiology, risk factors, and subsequent infections. Front. Microbiol. 9, 2419 (2018).
Stensen, D. B. et al. Circulating sex-steroids and Staphylococcus aureus nasal carriage in a general female population. Eur. J. Endocrinol. 184, 337–346 (2021).
Stensen, D. B. et al. Hormonal contraceptive use and Staphylococcus aureus nasal and throat carriage in a Norwegian youth population. PLoS ONE 14, e0218511 (2019).
Liu, Z. et al. Nasal decontamination for the prevention of surgical site infection in Staphylococcus aureus carriers. Cochrane Database Syst. Rev. 5, 012462 (2017).
Giefing-Kröll, C., Berger, P., Lepperdinger, G. & Grubeck-Loebenstein, B. How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell 14, 309–321 (2015).
Askim, A. et al. Epidemiology and outcome of sepsis in adult patients with Streptococcus pneumoniae infection in a Norwegian county 1993–2011: An observational study. BMC Infect. Dis. 16, 223 (2016).
Tolsma, V. et al. Sepsis severe or septic shock: Outcome according to immune status and immunodeficiency profile. Chest 146, 1205–1213 (2014).
Evans, L. et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intens. Care Med. 47, 1181 (2021).
Cadegiani, F. A., McCoy, J., Gustavo Wambier, C. & Goren, A. Early antiandrogen therapy with dutasteride reduces viral shedding, inflammatory responses, and time-to-remission in males with COVID-19: A randomized, double-blind, placebo-controlled interventional trial (EAT-DUTA AndroCoV Trial—Biochemical). Cureus 13, e13047 (2021).
Seeland, U. et al. Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med. 18, 369 (2020).

Auteurs

Randi Marie Mohus (RM)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway. randi.m.mohus@ntnu.no.
Clinic of Anesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Torgarden, Postboks 3250, 7006, Trondheim, Norway. randi.m.mohus@ntnu.no.

Lise T Gustad (LT)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Nord-Trøndelag Hospital Trust, Levanger, Norway.
Faculty of Health Sciences, Nord University, Levanger, Norway.

Anne-Sofie Furberg (AS)

Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Faculty of Health and Social Sciences, Molde University College, Molde, Norway.

Martine Kjølberg Moen (MK)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Clinic of Anesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Torgarden, Postboks 3250, 7006, Trondheim, Norway.

Kristin Vardheim Liyanarachi (KV)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Infectious Diseases, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Åsa Askim (Å)

Clinic of Anesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Torgarden, Postboks 3250, 7006, Trondheim, Norway.

Signe E Åsberg (SE)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

Andrew T DeWan (AT)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA.

Tormod Rogne (T)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA.

Gunnar Skov Simonsen (GS)

Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, Norway.
Research Group for Host-Microbe Interaction, Faculty of Health Sciences, UiT - The Arctic University of Norway, Tromsø, Norway.
Norwegian Institute of Public Health, Oslo, Norway.

Tom Ivar Lund Nilsen (TIL)

Clinic of Anesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Torgarden, Postboks 3250, 7006, Trondheim, Norway.
Department of Public Health and Nursing, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

Bjørn Olav Åsvold (BO)

Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Endocrinology, Clinic of Medicine, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Jan Kristian Damås (JK)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Infectious Diseases, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Department of Clinical and Molecular Medicine, Centre of Molecular Inflammation Research, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

Erik Solligård (E)

Gemini Center for Sepsis Research, Institute of Circulation and Medical Imaging, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Clinic of Anesthesia and Intensive Care, St. Olavs Hospital, Trondheim University Hospital, Torgarden, Postboks 3250, 7006, Trondheim, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH